BRAF and neoplasm: The use of BRAF inhibitors in BRAFV600E mutant PCP has provided excellent results in tumor suppression, but the efficient inhibitor for CTNNB1 mutation is not yet available, and rapid CP regrowth has also been reported after BRAF inhibitor treatment [8,9,10].